Combination of Botulinum Toxin A and Hyaluronic Acid Improved Facial Pore Enlargement Caused by Acne.
Abstract
[BACKGROUND] Acne often leads to enlarged pores on the facial skin, seriously affecting the patient's appearance. Topical and oral medications have poor efficacy in some cases of severe pore enlargement.
[OBJECTIVE] This study aimed to explore the clinical efficacy and safety of botulinum toxin A combined with hyaluronic acid in improving facial pore enlargement.
[METHOD] A retrospective study was conducted on 40 acne patients with enlarged pores. Botulinum toxin A and non-cross-linked hyaluronic acid compound were injected into the patient's face using mesotherapy with nine 32-gauge microneedles. VISIA was used to record the conditions of facial pores, texture, and porphyrins. The physician's assessment of the improvement score and the patient satisfaction evaluation are used to evaluate the treatment effect.
[RESULT] One month after treatment, the combination of botulinum toxin and non-cross-linked hyaluronic acid compound significantly improved facial pore enlargement. Although the effects decreased, the conditions of facial pores, texture, and porphyrins 4 months after treatment still had a significant difference from those at baseline.
[CONCLUSION] The combination of botulinum toxin A and non-cross-linked hyaluronic acid compound is safe and effective in treating enlarged pores, indicating its promotional value.
[OBJECTIVE] This study aimed to explore the clinical efficacy and safety of botulinum toxin A combined with hyaluronic acid in improving facial pore enlargement.
[METHOD] A retrospective study was conducted on 40 acne patients with enlarged pores. Botulinum toxin A and non-cross-linked hyaluronic acid compound were injected into the patient's face using mesotherapy with nine 32-gauge microneedles. VISIA was used to record the conditions of facial pores, texture, and porphyrins. The physician's assessment of the improvement score and the patient satisfaction evaluation are used to evaluate the treatment effect.
[RESULT] One month after treatment, the combination of botulinum toxin and non-cross-linked hyaluronic acid compound significantly improved facial pore enlargement. Although the effects decreased, the conditions of facial pores, texture, and porphyrins 4 months after treatment still had a significant difference from those at baseline.
[CONCLUSION] The combination of botulinum toxin A and non-cross-linked hyaluronic acid compound is safe and effective in treating enlarged pores, indicating its promotional value.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 5 | |
| 재료 | hyaluronic acid
|
히알루론산 | dict | 5 | |
| 해부 | skin
|
scispacy | 1 | ||
| 해부 | oral
|
scispacy | 1 | ||
| 해부 | pores
|
scispacy | 1 | ||
| 합병증 | Facial Pore
|
scispacy | 1 | ||
| 약물 | hyaluronic acid compound
|
scispacy | 1 | ||
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 약물 | porphyrins
|
scispacy | 1 | ||
| 약물 | porphyrins 4
|
scispacy | 1 | ||
| 질환 | Acne
|
C0001144
Acne Vulgaris
|
scispacy | 1 | |
| 기타 | Botulinum Toxin A
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Humans; Hyaluronic Acid; Botulinum Toxins, Type A; Retrospective Studies; Female; Acne Vulgaris; Adult; Young Adult; Male; Treatment Outcome; Face; Patient Satisfaction; Dermal Fillers; Cosmetic Techniques; Adolescent; Skin; Drug Therapy, Combination; Injections, Intradermal
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.